ð¡ ææ°ã®å šåœèª¿æ»ã§æããã«ãªã£ãEDã®å®æ ïŒ20ä»£ç·æ§ãšé«éœ¢å±€ã«å€ãåŸå
åèµ·äžå šïŒEDïŒã¯ãç·æ§ã®æ§æ©èœã«é¢ããæ©ã¿ã®äžã§ãç¹ã«å€ãã®æ¹ãçµéšããå¯èœæ§ã®ããçç¶ã§ãããããããã®å®æ ãç¹ã«è¥ãäžä»£ã«ãããç¶æ³ã«ã€ããŠã¯ããããŸã§ååã«ç¥ãããŠããŸããã§ãããä»åãæ¥æ¬æ§æ©èœåŠäŒã宿œããå€§èŠæš¡ãªå šåœèª¿æ»ã«ãããæ¥æ¬ã®ç·æ§ã«ãããEDã®æç çãšã幎霢ããããŠçµå©ã®æç¡ãšã®è峿·±ãé¢é£æ§ãæããã«ãªããŸããã
ãã®èª¿æ»çµæã¯ãEDãç¹å®ã®å¹Žéœ¢å±€ãç¶æ³ã«éå®ããããã®ã§ã¯ãªããç¹ã«20代ã®è¥ãç·æ§ã«ãšã£ãŠã決ããŠä»äººäºã§ã¯ãªãåé¡ã§ããããšã瀺åããŠããŸããæ¬èšäºã§ã¯ããã®éèŠãªç ç©¶ã®æŠèŠãšãç§ãã¡ã®å®ç掻ã«åœ¹ç«ã€ãã€ã³ãã«ã€ããŠè©³ãã解説ããŸãã
ð ç ç©¶ã®æŠèŠãšç®ç
ãã®ç ç©¶ã®äž»ãªç®çã¯ãæ¥æ¬ã®ç·æ§ã«ãããåèµ·äžå šïŒEDïŒã®æç çãå šåœèŠæš¡ã§èª¿æ»ããç¹ã«æªå©ç·æ§ãšæ¢å©ç·æ§ã®éã§EDã®æç çã«ã©ã®ãããªéããããã®ãããããŠè¥å¹Žç·æ§ã«ãããEDã®æç çã®é«ããå©å§»ç¶æ³ãšã¯é¢ä¿ãªãååšããã®ããæããã«ããããšã§ããã
EDã¯ãæ§äº€æã«ååãªåèµ·ãåŸãããªãããŸãã¯ç¶æã§ããªãç¶æ ãæããŸãããã®åé¡ã¯ã身äœçãªèŠå ã ãã§ãªããå¿ççãªèŠå ãã©ã€ãã¹ã¿ã€ã«ãšãæ·±ãé¢é£ããŠãããšèããããŠããŸãã
ð¬ 調æ»ã®æ¹æ³
ãã®èª¿æ»ã¯ã2023å¹Žã«æ¥æ¬æ§æ©èœåŠäŒã宿œãããã€ã³ã¿ãŒãããããŒã¹ã®å šåœæšªæèª¿æ»â»1ã®ããŒã¿ãçšããŠåæãããŸããã察象ãšãªã£ãã®ã¯ã20æ³ãã79æ³ãŸã§ã®ç·æ§6,228人ã§ãã
- EDã®å®çŸ©: åèµ·ã®ç¡¬ããèªå·±è©äŸ¡ãããErection Hardness Score (EHS)â»2ãã2以äžã®å ŽåãEDãšå®çŸ©ããŸãããEHSã¯ãåèµ·ã®ç¡¬ãã0ïŒå šã硬ããªããªãïŒãã4ïŒå®å šã«ç¡¬ããæ§äº€ã«ååïŒã®5段éã§è©äŸ¡ããææšã§ãã
- åææ¹æ³: åå è ãå©å§»ç¶æ³ïŒæªå©ã»æ¢å©ïŒãšå¹Žéœ¢å±€ã§å±€å¥åããè¥æºãç³å°¿ç ãé«è¡å§ãè質ç°åžžçãæ ¢æ§è èç ãå¿è¡ç®¡çŸæ£ãå«ç ãªã©ã®äœµåçŸæ£â»3ã調æŽããå€å€éè§£æâ»4ãè¡ããŸããããŸãã幎霢ãšEDæç çã®åŸåãè©äŸ¡ããããã«ãRestricted cubic spline regressionâ»5ãšããçµ±èšææ³ãçšããããŸããã
- ãã®ä»ã®è©äŸ¡: æ§çè¡åïŒæ§äº€é »åºŠãèªæ °é »åºŠïŒãæ§ç欲æ±ã«ã€ããŠããåŠ¥åœæ§ãæ€èšŒããã質å祚ãçšããŠè©äŸ¡ãããŸããã
â»1 暪æèª¿æ»: ããäžæç¹ã§ã®éå£ã®ç¶æ³ãç¹æ§ã調æ»ããç ç©¶æ¹æ³ã§ãã
â»2 Erection Hardness Score (EHS): åèµ·ã®ç¡¬ãã客芳çã«è©äŸ¡ããããã®ç°¡åãªææšã§ãå»ççŸå Žã§ãåºãçšããããŠããŸãã
â»3 䜵åçŸæ£: äž»ãªç
æ°ãçç¶ã«å ããŠãåæã«ååšããä»ã®ç
æ°ãå¥åº·åé¡ã®ããšã§ãã
â»4 å€å€éè§£æ: è€æ°ã®èŠå ïŒå€æ°ïŒãçµæã«ã©ã®ããã«åœ±é¿ããããåæã«åæããçµ±èšææ³ã§ãã
â»5 Restricted cubic spline regression: è€éãªéç·åœ¢é¢ä¿ïŒçŽç·ã§ã¯ãªãé¢ä¿ïŒãåæããéã«çšããããçµ±èšææ³ã®äžã€ã§ã幎霢ãšEDæç
çã®ãããªé¢ä¿ãæè»ã«ã¢ãã«åã§ããŸãã
ð äž»èŠãªèª¿æ»çµæã®ãã€ã³ã
ãã®èª¿æ»ã§æããã«ãªã£ãäž»ãªãã€ã³ãã¯ä»¥äžã®éãã§ãã
æªå©ç·æ§ãšæ¢å©ç·æ§ã®æ¯èŒ
- æªå©ç·æ§ã¯æ¢å©ç·æ§ã«æ¯ã¹ãŠè¥ããè¥æºãç³å°¿ç ãªã©ã®äœµåçŸæ£ãå°ãªãåŸåã«ãããŸããã
- ããããè¥å¹Žå±€ã§ã¯ãæªå©ç·æ§ã®æ¹ãæ¢å©ç·æ§ãããEDã®æç çãææã«é«ãããšã倿ããŸããã
幎霢局å¥ã®EDæç ç
ç¹ã«æ³šç®ãã¹ãã¯ã20ä»£ç·æ§ã®EDæç çã®é«ãã§ãã以äžã®è¡šã«äž»èŠãªçµæããŸãšããŸããã
| 幎霢局 | æªå©ç·æ§ã®EDæç ç | æ¢å©ç·æ§ã®EDæç ç | 調æŽåŸã®æç çå·® |
|---|---|---|---|
| 20ïœ29æ³ | 25.5% | 17.8% | 7.3% (p<0.05) |
| 30ïœ39æ³ | åæ§ã®åŸå | åæ§ã®åŸå | ïŒå ·äœçãªæ°å€ã¯æé²ã«èšèŒãªãïŒ |
| 40ïœ49æ³ | åæ§ã®åŸå | åæ§ã®åŸå | ïŒå ·äœçãªæ°å€ã¯æé²ã«èšèŒãªãïŒ |
- 20ä»£ç·æ§ã§ã¯ãæªå©ç·æ§ã®çŽ4人ã«1人ãEDãæ±ããŠãããšããçµæã¯ãéåžžã«è¡æçã§ãã
- 30代ã40代ååã®ç·æ§ã§ããæªå©ç·æ§ã®æ¹ãæ¢å©ç·æ§ãããEDæç çãé«ããšããåæ§ã®åŸåãèŠãããŸããã
幎霢ãšEDæç çã®Uååååž
- å©å§»ç¶æ³ã䜵åçŸæ£ã調æŽããŠåæããçµæãEDã®æç çã¯å¹Žéœ¢ãšãšãã«Uååã®ååžã瀺ãããšãåãããŸãããã€ãŸããæãEDæç çãäœãã®ã¯40æ³ååŸã§ããããããããè¥ã20代ããé«éœ¢ã«ãªãã«ã€ããŠæç çãé«ããªãåŸåãèŠãããŸããã
- ç¹ã«ã20ä»£ç·æ§ã®EDæç çã¯ã30代ã®ç·æ§ãããææã«é«ããŸãŸã§ããããšã匷調ãããŠããŸãã
æ§çè¡åãšæ¬²æ±
- æªå©ç·æ§ã¯ãæ¢å©ç·æ§ã«æ¯ã¹ãŠæ§äº€é »åºŠãšæ§ç欲æ±ãäœãåŸåã«ãããŸããã
- äžæ¹ã§ãèªæ °è¡çºã®é »åºŠã¯æªå©ç·æ§ã®æ¹ãé«ããšããçµæãåºãŠããŸãã
ð€ ç ç©¶çµæããã®èå¯
ãã®èª¿æ»çµæã¯ãæ¥æ¬ã®ç·æ§ã«ãããEDã®å®æ ã«ã€ããŠããã€ãã®éèŠãªç€ºåãäžããŠããŸãã
ãŸããæªå©ç·æ§ãç¹ã«è¥å¹Žå±€ã«ãããŠæ§æ©èœã®äœäžãé¡èã§ããããšãæããã«ãªããŸãããããã¯ãæªå©ç·æ§ãæ¢å©ç·æ§ã«æ¯ã¹ãŠäœµåçŸæ£ãå°ãªãã«ããããããèŠãããåŸåã§ãããåã«èº«äœçãªå¥åº·ç¶æ ã ãã§ã¯èª¬æã§ããªãèŠå ãé¢äžããŠããå¯èœæ§ã瀺åããŠããŸãã
ããã«éèŠãªã®ã¯ã20ä»£ç·æ§ã®EDæç çã®é«ãããå©å§»ç¶æ³ãšã¯ç¬ç«ããŠååšããŠãããšããç¹ã§ããããã¯ãEDã®åå ãåã«ããŒãããŒã®æç¡ãæ§è¡çºã®æ©äŒã®å€å¯¡ã ãã§ã¯ãªãããšãæå³ããŸããç ç©¶è ãã¡ã¯ããã®çŸè±¡ã®èæ¯ã«ã¯ãå¿ç瀟äŒçèŠå â»6ãã©ã€ãã¹ã¿ã€ã«èŠå ã倧ããå¯äžããŠããå¯èœæ§ãææããŠããŸãã
äŸãã°ãçŸä»£ç€ŸäŒã«ãããè¥å¹Žå±€ã®ã¹ãã¬ã¹ã粟ç¥çãªå¥åº·åé¡ãé床ãªããžã¿ã«ããã€ã¹ã®äœ¿çšãç¡ç äžè¶³ãéåäžè¶³ãé£ç掻ã®ä¹±ããªã©ããæ§æ©èœã«åœ±é¿ãäžããŠããå¯èœæ§ãèããããŸãããŸããæ§ã«é¢ããæ å ±éå€ããSNSãªã©ã§ã®æ¯èŒã«ãããã¬ãã·ã£ãŒããå¿ççãªèŠå ãšããŠé¢äžããŠãããããããŸããã
æªå©ç·æ§ã§æ§äº€é »åºŠãæ§ç欲æ±ãäœãäžæ¹ã§ãèªæ °é »åºŠãé«ããšããçµæãè峿·±ãç¹ã§ããããã¯ãããŒãããŒãšã®æ§è¡çºã®æ©äŒãå°ãªãããšããæ§çãªæ¬²æ±ãæºãããã«ããç¶æ³ãèæ¯ã«ããã®ãããããŸããããEDãšã®è€éãªé¢é£æ§ã«ã€ããŠã¯ãããªãç ç©¶ãå¿ èŠã§ãã
ãããã®çºèŠã¯ãè¥å¹Žæäººæãç·æ§ã®æ§æ©èœã®å¥åº·ã«ãšã£ãŠãèåŒ±ãªææãã§ããå¯èœæ§ã瀺ããŠããããã®äžä»£ã«å¯Ÿããæ©æã®ä»å ¥æŠç¥ã®å¿ èŠæ§ã匷ã瀺åããŠããŸãã
â»6 å¿ç瀟äŒçèŠå : å人ã®å¿çç¶æ ãã瀟äŒçãªç°å¢ã人éé¢ä¿ãªã©ãå¥åº·ãè¡åã«äžãã圱é¿ãæããŸãã
ð¡ å®ç掻ã§åœ¹ç«ã€ã¢ããã€ã¹
ãã®èª¿æ»çµæãåããŠãç§ãã¡ã®å®ç掻ã§EDã®äºé²ãæ¹åã®ããã«ã§ããããšã¯äœã§ãããããç¹ã«è¥ãäžä»£ã®æ¹ã ã«åããŠãããã€ãã®ã¢ããã€ã¹ããŸãšããŸããã
- EDã¯å¹Žéœ¢ã«é¢ãããèµ·ããããåé¡ãšèªèãã: EDã¯é«éœ¢è ã ãã®åé¡ã§ã¯ãããŸããã20代ã§ãEDã«ãªãå¯èœæ§ã¯ååã«ãããŸããæ§æ©èœã«é¢ããæ©ã¿ãäžäººã§æ±ã蟌ãŸãããªãŒãã³ã«èããããšã倧åã§ãã
- å¥åº·çãªã©ã€ãã¹ã¿ã€ã«ãå¿ããã:
- ãã©ã³ã¹ã®åããé£äº: æ é€è±å¯ãªé£äºãå¿ãããå å·¥é£åãé«èèªé£ã¯æ§ããã«ããŸãããã
- é©åºŠãªéå: 宿çãªéåã¯ãå¿è¡ç®¡ç³»ã®å¥åº·ãä¿ã¡ãè¡æµãæ¹åããã¹ãã¬ã¹ã軜æžããŸãã
- ååãªç¡ç : ç¡ç äžè¶³ã¯ãã«ã¢ã³ãã©ã³ã¹ãã¹ãã¬ã¹ã¬ãã«ã«åœ±é¿ãäžããEDã®ãªã¹ã¯ãé«ããå¯èœæ§ããããŸãã
- ã¹ãã¬ã¹ç®¡ç: ã¹ãã¬ã¹ã¯EDã®å€§ããªèŠå ã®äžã€ã§ããè¶£å³ããªã©ã¯ãŒãŒã·ã§ã³ãçæ³ãªã©ã§ã¹ãã¬ã¹ãé©åã«ç®¡çããŸãããã
- é床ãªé£²é ãå«ç ãæ§ãã: å«ç ã¯è¡ç®¡ãåçž®ãããè¡æµãæªåããããããEDã®äž»èŠãªãªã¹ã¯å åã§ããé床ãªé£²é ãæ§æ©èœã«æªåœ±é¿ãåãŒããŸãã
- æ§ã«é¢ããæ©ã¿ãå°éå®¶ã«çžè«ãã: ããEDã®çç¶ãæããããæ¥ããããããã«æ³å°¿åšç§ãæ§æ©èœå°éå»ã«çžè«ããŸããããæ©æã«é©åãªèšºæãšæ²»çãåããããšã§ãæ¹åããå¯èœæ§ãé«ãŸããŸããã€ã³ã¿ãŒãããäžã®äžç¢ºããªæ å ±ã«æããããªãããã«æ³šæããŠãã ããã
- ããŒãããŒãšã®ã³ãã¥ãã±ãŒã·ã§ã³: ããŒãããŒãããå Žåã¯ãæ§ã«é¢ããæ©ã¿ãäžå®ãå ±æããäžç·ã«è§£æ±ºçãæ¢ãããšã倧åã§ãããªãŒãã³ãªã³ãã¥ãã±ãŒã·ã§ã³ã¯ãé¢ä¿æ§ã®æ¹åã«ãã€ãªãããŸãã
- 粟ç¥çãªå¥åº·ã«ãç®ãåãã: ãã€ç ãäžå®é害ãªã©ã®ç²Ÿç¥çãªåé¡ã¯ãEDãšå¯æ¥ã«é¢é£ããŠããããšããããŸããå¿ èŠã§ããã°ãå¿çå ç§ã粟ç¥ç§ã®å°éå»ã«çžè«ããããšãæ€èšããŸãããã
ð§ ç ç©¶ã®éçãšä»åŸã®èª²é¡
ãã®ç ç©¶ã¯å€§èŠæš¡ãªå šåœèª¿æ»ã§ãããæ¥æ¬ã®ç·æ§ã«ãããEDã®å®æ ãæããã«ããäžã§éåžžã«è²ŽéãªããŒã¿ãæäŸããŸããããããã€ãã®éçãååšããŸãã
- ã€ã³ã¿ãŒããã調æ»ã®éç: åçè ãã€ã³ã¿ãŒããããŠãŒã¶ãŒã«éå®ããããããç¹å®ã®å±€ã«åãïŒãã€ã¢ã¹ïŒãçããå¯èœæ§ããããŸãããŸããèªå·±ç³åã«åºã¥ãããŒã¿ã§ãããããåçã®æ£ç¢ºæ§ã«ã°ãã€ããããå¯èœæ§ãåŠå®ã§ããŸããã
- 暪æèª¿æ»ã§ããããš: ããäžæç¹ã®ããŒã¿ãåæããŠãããããEDãšä»ã®èŠå ãšã®éã«å æé¢ä¿ïŒåå ãšçµæã®é¢ä¿ïŒãæç¢ºã«ç¹å®ããããšã¯ã§ããŸãããäŸãã°ããã¹ãã¬ã¹ãå€ãããEDã«ãªã£ããã®ãããEDã«ãªã£ãããã¹ãã¬ã¹ãå¢ãããã®ãããã®èª¿æ»ã ãã§ã¯å€æã§ããŸããã
- EDã®å®çŸ©: EHSã«åºã¥ãEDã®å®çŸ©ã¯ç°¡äŸ¿ã§ããããã詳现ãªèšºæåºæºãæ€æ»ãçšããå Žåãšã¯ç°ãªãçµæãåºãå¯èœæ§ããããŸãã
- å¿ç瀟äŒçèŠå ã®è©äŸ¡: æé²ããã¯ãå¿ç瀟äŒçèŠå ã®å ·äœçãªè©äŸ¡æ¹æ³ãéå®çã§ããããšã䌺ããŸããä»åŸã®ç ç©¶ã§ã¯ããããã®èŠå ããã詳现ã«è©äŸ¡ããEDãšã®é¢é£æ§ãæ·±ãæãäžããããšã課é¡ãšãªããŸãã
ãããã®éçãèžãŸããä»åŸã¯ç¹å®ã®éå£ãé·æçã«è¿œè·¡ãã瞊æç ç©¶ããç¹å®ã®ä»å ¥ãEDã«äžãã圱é¿ãè©äŸ¡ããä»å ¥ç ç©¶ãªã©ãå¿ èŠãšãããŠããŸããããã«ãããEDã®çã®åå ãç¹å®ãããã广çãªäºé²ã»æ²»çæŠç¥ã®éçºã«ã€ãªããããšãæåŸ ãããŸãã
ãŸãšã
ä»åã®æ¥æ¬æ§æ©èœåŠäŒã«ããå šåœèª¿æ»ã¯ãæ¥æ¬ã®ç·æ§ã«ãããåèµ·äžå šïŒEDïŒã®å®æ ã«å ãåœãŠãç¹ã«20代ã®è¥ãç·æ§ãšé«éœ¢å±€ã§EDã®æç çãé«ããšããUååã®åŸåãæããã«ããŸãããé©ãã¹ãããšã«ã20ä»£ç·æ§ã®EDæç çã¯å©å§»ç¶æ³ãšã¯ç¬ç«ããŠããããã®èæ¯ã«ã¯å¿ç瀟äŒçèŠå ãã©ã€ãã¹ã¿ã€ã«ã倧ããé¢äžããŠããå¯èœæ§ã瀺åãããŠããŸãã
ãã®ç ç©¶çµæã¯ãEDãç¹å®ã®å¹Žéœ¢å±€ãç¶æ³ã«éå®ããããã®ã§ã¯ãªããçŸä»£ç€ŸäŒãçããå€ãã®ç·æ§ã«ãšã£ãŠèº«è¿ãªå¥åº·åé¡ã§ããããšãç§ãã¡ã«æããŠãããŸããæ§æ©èœã®å¥åº·ã¯ãåã«æ§ç掻ã®è³ªã ãã§ãªããå šäœçãªç掻ã®è³ªã粟ç¥çãªå¥åº·ã«ãæ·±ã圱é¿ããŸããEDã¯æ²»çå¯èœãªçç¶ã§ãããäžäººã§æ©ãŸããå¥åº·çãªã©ã€ãã¹ã¿ã€ã«ãå¿ãããå¿ èŠã§ããã°æ©æã«å°éå»ã«çžè«ããããšãéåžžã«éèŠã§ãããã®èª¿æ»ããç·æ§ã®æ§æ©èœã®å¥åº·ã«å¯Ÿããæèãé«ããããè¯ããµããŒãäœå¶ã®æ§ç¯ã«ã€ãªããããšãæåŸ ããŸãã
ð é¢é£ãªã³ã¯é
- æ¥æ¬æ§æ©èœåŠäŒ
- æ¥æ¬æ³å°¿åšç§åŠäŒ
- åçåŽåç
- æ¥æ¬å»åž«äŒ
- åœç«åœéå»çç ç©¶ã»ã³ã¿ãŒ
æžèªæ å ±
| DOI | 10.5534/wjmh.260157 |
|---|---|
| PMID | 42845170 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42845170/ |
| çºè¡å¹Ž | 2026 |
| èè å | Tsujimura Akira, Fukuhara Shinichiro, Chiba Koji, Yoshizawa Tsuyoshi, Tomoe Hikaru, Shirai Masato, Kimura Kazunori, Kikuchi Eiji, Maeda Eri, Sato Yoshikazu, Nagai Atsushi, Nagao Koichi, Sasaki Haruaki, |
| èè æå± | Department of Urology, Juntendo University Urayasu Hospital, Urayasu, Japan. atsujimu@juntendo.ac.jp.; Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.; Department of Urology, Nihon University School of Medicine, Tokyo, Japan.; Department of Urology, Sayama Sougou Clinic, Saitama, Japan.; Department of Urology, Juntendo University Urayasu Hospital, Urayasu, Japan.; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan.; Department of Public Health, Faculty of Medicine, Hokkaido University, Sapporo, Japan.; Department of Urology, Sanjukai Urological Hospital, Sapporo, Japan.; Department of Management, Kawasaki Medical School Hospital, Kurashiki, Japan.; Department of Urology, Faculty of Medicine, Toho University, Tokyo, Japan.; Department of Urology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan. |
| éèªå | World J Mens Health |